The American Journal of Managed Care

Delgocitinib Is Redefining Chronic Hand Eczema Treatment: A Q&A With Raj Chovatiya, MD, PhD, MSCI

Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI. Chronic hand eczema (CHE) ...
Medscape

Traditional Hand Eczema Treatments May Face Obsolescence

NEW YORK, NY — For immediate control of a hand eczema flare, the old soak and smear approach with moisturizers or corticosteroids might live on, but they are moving to the back of the shelf for ...
Healio

Q&A: Managing ‘the biggest triggers’ for chronic hand eczema with Bruce Brod, MD

The cold, dry air of winter brings challenges for those with chronic hand eczema. Chronic hand eczema (CHE), defined as hand ...
Monthly Prescribing Reference

Delgocitinib Cream Under Review for Chronic Hand Eczema

A regulatory decision is expected in the second half of 2025. The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for delgocitinib cream as a treatment for ...
Healio

Delgocitinib cream safe, efficacious in chronic hand eczema

Please provide your email address to receive an email when new articles are posted on . In two phase 3 trials, delgocitinib cream improved hand eczema in a greater proportion of patients vs. vehicle.
Medical Dialogues

Tralokinumab Shows Sustained Efficacy in Hand Atopic Dermatitis: Study

The ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic dermatitis. All primary and secondary ...
Medscape

Chronic Hand Eczema: Longer-Term Data Reported for Topical Treatment

San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with ...
FiercePharma

Leo Pharma, awaiting FDA approval decision, finds dermatologists are frustrated with current chronic hand eczema treatments

A new survey commissioned by Leo Pharma confirms there’s plenty of room in the market for its chronic hand eczema treatment Anzupgo, which is currently under review by the FDA. The survey, conducted ...
MedPage Today

Delgocitinib Cream More Effective Than Oral Alitretinoin for Severe Hand Eczema

Treatment options for severe chronic hand eczema are limited and carry troublesome adverse effects. Delgocitinib cream had superior efficacy compared with oral alitretinoin for this patient population ...
Business Wire

LEO Pharma initiates the first Phase 3 clinical trial with delgocitinib cream in adult patients with moderate-to-severe chronic hand eczema (CHE)

BALLERUP, Denmark--(BUSINESS WIRE)--NOT FOR DISTRIBUTION IN THE UK OR IRELAND LEO Pharma A/S, a global leader in medical dermatology, today announced it has enrolled the first adult patient in the ...
The American Journal of Managed Care

New Dermatologic Therapies Make Waves at Maui Derm 2026

Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...